Director, Bloomberg-Kimmel Institute for Cancer Immunotherapy at Johns Hopkins University Medicine
Cancer Immunology
EDUCATION
BA – Johns Hopkins University
MD – Johns Hopkins University School of Medicine
PhD – Johns Hopkins University School of Medicine
AWARDS AND ACCOLADES
Cancer Research Institute Investigators Award, 2011
Medical Student Basic Science Teaching Award
National Academy of Inventors, 2018
COMPANIES AND BOARDS
Co-Founder: Amplimmune (acquired by MedImmune/AstraZeneca), Jounce (NAS:JNCE), Potenza (Acquired by Astellas), Tizona, Ervaxx, DNAtrix
Scientific Advisory Board: WindMil, Five Prime (NASDAQ:FPRX), DNAtrix, Dracen Pharmaceuticals, Aduro (NASDAQ:ADRO) Pharmaceuticals
